Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled time : 16:00 save search
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
Published: 2024-04-16 (Crawled : 16:00) - biospace.com/
PTPI | $0.6502 -2.97% 1.02% 200K
|
|
| O: 9.85%
H: 4.63%
C: -18.04%
fda positive pharmaceuticals for technology response
Alnylam Reports Positive KARDIA-2 Topline Study Results Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care Antihypertensives
Published: 2024-03-05 (Crawled : 16:00) - biospace.com/
SNY | News | $47.15 1.84% 1.75% 2M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
ALNY | $145.79 0.96% 0.94% 400K
|
Health Technology
|
| O: -0.73%
H: 1.52%
C: 0.5%
positive blood care topline results study
Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults
Published: 2024-02-29 (Crawled : 16:00) - biospace.com/
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: 0.11%
H: 0.44%
C: -1.88%
abrysvo positive rsv
Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154
Published: 2023-12-13 (Crawled : 16:00) - biospace.com/
STTK | $9.3 -2.92% -2.9% 310K
|
Health Technology
|
| O: 107.58%
H: 23.74%
C: 10.96%
sl-1721 positive ongoing expansion topline trial
Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association
Published: 2023-11-28 (Crawled : 16:00) - globenewswire.com
CHRS | $2.18 5.31% 5.48% 1.3M
|
Health Technology
|
| O: -1.55%
H: 12.83%
C: 10.47%
piter-02 association positive publication treatment medical trial results
Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
CADL | $5.54 7.16% 6.85% 570K
|
|
| O: 4.63%
H: 2.0%
C: -24.97%
can-2409 positive cancer pancreatic trial therapeutics
Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms’ Tumor 1 Positive Cancers at SITC 2023
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
CUE | $1.57 0.64% 0.0% 180K
|
Health Technology
|
| O: 1.35%
H: 16.44%
C: 8.89%
cue-101 positive cue cancer biopharma tumor cue-102 trials
HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
HOOK | $0.707 -3.55% -2.88% 870K
|
Health Technology
|
| O: 2.33%
H: 13.05%
C: 4.73%
hb-200 pharma biomarker positive cancer immunotherapy
IN8bio Presents Positive Data Update from Induced Pluripotent Stem Cell (iPSC) Platform at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
INAB | $0.9999 -2.92% -0.49% 210K
|
|
| O: 4.0%
H: 5.77%
C: 0.0%
positive update cancer cell immunotherapy meeting platform
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Published: 2023-11-03 (Crawled : 16:00) - prnewswire.com
ONCY | $1.045 -3.24% -3.35% 180K
|
Health Technology
|
| O: 0.0%
H: 0.56%
C: -3.91%
biotech positive
RAPT Therapeutics Announces Positive Data, Including Objective Response Rates and Progression-Free Survival, from its Phase 2 Trial of FLX475 in Combination with a Checkpoint Inhibitor in Patients with Advanced NSCLC
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
RAPT | $7.86 -1.13% -1.15% 310K
|
Health Technology
|
| O: 1.97%
H: 12.63%
C: 6.97%
flx475 positive trial therapeutics response
Molecular Partners Presents Updated Positive Data from Ongoing Phase 1 Trial of MP0317 (FAP X CD40) Monotherapy in Patients with Advanced Solid Tumors at the 2023 SITC Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
MOLN | $3.88 16.87% -3.54% 3.4K
|
Professional, Scientific, and T...
|
| O: 0.72%
H: 9.74%
C: 9.74%
mp0317 tumors positive ongoing meeting trial molecular
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
XAIR | $1.21 -1.63% 0.0% 580K
|
Technology Services
|
| O: 2.03%
H: 3.98%
C: -8.76%
beyond tumors positive cancer immunotherapy meeting therapy
Thumzup Surpasses $1 Million in Regulation A+ Subscriptions after Unveiling Positive User and Advertiser Data from Posts Made on its AdTech App
Published: 2023-10-04 (Crawled : 16:00) - globenewswire.com
TZUP | News | $5.85 77.33% 600
|
n/a
| Email alert
Add to watchlist
thumzup positive
Ascendis Pharma Receives Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) for Adults with Chronic Hypoparathyroidism
Published: 2023-09-14 (Crawled : 16:00) - globenewswire.com
ASND | $142.1 1.38% 1.39% 250K
|
Health Technology
|
| O: 0.55%
H: 3.07%
C: 2.59%
pharma chmp positive
Skye Bioscience Receives Positive Safety Review for Final Cohort of Fully-Enrolled Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-07-13 (Crawled : 16:00) - biospace.com/
SKYE | $14.81 -8.24% -8.98% 220K
|
Transportation and Warehousing
|
| O: -6.1%
H: 6.5%
C: 4.5%
sbi-100 review positive bioscience study
Skye Bioscience Receives Positive Safety Review in First Multiple-Administration Cohort of Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published: 2023-05-15 (Crawled : 16:00) - biospace.com/
SKYE | $14.81 -8.24% -8.98% 220K
|
Transportation and Warehousing
|
| O: -0.67%
H: 16.11%
C: 7.38%
sbi-100 review positive bioscience study
Kiora Pharmaceuticals Reports First Quarter Results; Positive Clinical Data Driving Significant Progress Advancing Pipeline of Eye Disease Treatments
Published: 2023-05-09 (Crawled : 16:00) - biospace.com/
KPRX | $0.485 -1.08% -1.07% 97K
|
Manufacturing
|
| O: -0.79%
H: 7.57%
C: 0.8%
disease positive pipeline pharmaceuticals eye
Skye Bioscience Receives Positive Safety Review of SBI-100 Ophthalmic Emulsion After Second Cohort of Phase 1 Study
Published: 2023-02-23 (Crawled : 16:00) - biospace.com/
SKYE | $14.81 -8.24% -8.98% 220K
|
Transportation and Warehousing
|
| O: 1.01%
H: 25.67%
C: 7.67%
sbi-100 review positive bioscience study ophthalmic emulsion phase 1
Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study
Published: 2023-02-16 (Crawled : 16:00) - biospace.com/
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: -0.39%
H: 0.07%
C: -0.46%
talzenna positive study
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
PROK | $2.72 33.33% 24.58% 2.6M
|
Your saved searches
Save your searches and get alerts when important news are released.